pubmed-article:6703889 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6703889 | lifeskim:mentions | umls-concept:C0026769 | lld:lifeskim |
pubmed-article:6703889 | lifeskim:mentions | umls-concept:C0015672 | lld:lifeskim |
pubmed-article:6703889 | lifeskim:mentions | umls-concept:C0231220 | lld:lifeskim |
pubmed-article:6703889 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:6703889 | pubmed:dateCreated | 1984-3-30 | lld:pubmed |
pubmed-article:6703889 | pubmed:abstractText | Symptomatic fatigue has not been investigated previously in a multiple sclerosis population. Potential subjects were the 78% of 656 individuals with multiple sclerosis who indicated in a previous study that they experienced symptomatic fatigue. Three hundred nine subjects (60%) returned a follow-up questionnaire on symptomatic fatigue. Ninety percent described fatigue as "tiredness or the need to rest," but 43% of them indicated that "sleepiness" was part of the symptomatology. In 48% fatigue made other MS symptoms worse. Fatigue tended to occur in the late afternoon and evening. It occurred almost daily for more than 66% of the subjects. In 47% of the subjects fatigue usually subsided within a few hours; in other subjects occurrences were of variable length (40%) or lasted between 6 and 24 hours (8%). Ninety percent said that fatigue was worse at warmer environmental temperatures. Fatigue was worse for 83% after "vigorous exercise" and for 64% after "moderate exercise" although 15% reported that moderate exercise helped to reduce fatigue. Meditation, some drugs, and cooling with water reduced fatigue in a majority of the small proportion of the population trying these techniques. A planned daily schedule of activity and rest seemed to be a partially effective response to symptomatic fatigue for the majority of subjects studied. | lld:pubmed |
pubmed-article:6703889 | pubmed:language | eng | lld:pubmed |
pubmed-article:6703889 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6703889 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:6703889 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6703889 | pubmed:month | Mar | lld:pubmed |
pubmed-article:6703889 | pubmed:issn | 0003-9993 | lld:pubmed |
pubmed-article:6703889 | pubmed:author | pubmed-author:KraftG HGH | lld:pubmed |
pubmed-article:6703889 | pubmed:author | pubmed-author:FrealJ EJE | lld:pubmed |
pubmed-article:6703889 | pubmed:author | pubmed-author:CoryellJ KJK | lld:pubmed |
pubmed-article:6703889 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6703889 | pubmed:volume | 65 | lld:pubmed |
pubmed-article:6703889 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6703889 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6703889 | pubmed:pagination | 135-8 | lld:pubmed |
pubmed-article:6703889 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:meshHeading | pubmed-meshheading:6703889-... | lld:pubmed |
pubmed-article:6703889 | pubmed:year | 1984 | lld:pubmed |
pubmed-article:6703889 | pubmed:articleTitle | Symptomatic fatigue in multiple sclerosis. | lld:pubmed |
pubmed-article:6703889 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6703889 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6703889 | lld:pubmed |